VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Novo Nordisk A/S vs Synopsys, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisSynopsys, Inc.
SNPS · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Synopsys, Inc.'s moat claims, evidence, and risks.
View SNPS analysisComparison highlights
- Moat score: both at 85 / 100.
- Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); Synopsys, Inc. has 2 segments (75.2% in Design Automation).
- Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; Synopsys, Inc. has 5 across 2.
Primary market context
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Synopsys, Inc.
Design Automation
Electronic design automation (EDA) software and silicon-to-systems simulation & analysis tools
Global
Semiconductor and systems companies (chip/system designers)
Software + hardware tooling provider / platform
75.2%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Novo Nordisk A/S strengths
Synopsys, Inc. strengths
Segment mix
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Synopsys, Inc. segments
Full profile >Design Automation
Oligopoly
Design IP
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.